PharmaCyte Biotech, Inc. - Current Ratio

The Current Ratio as of July 2026 (TTM) for PharmaCyte Biotech, Inc. (PMCB) is 45.28

According to PharmaCyte Biotech, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 45.28. This represents a change of 100.76% compared to the average of 22.55 of the last 4 quarters.

PharmaCyte Biotech, Inc. (PMCB) Historical Current Ratio (quarterly & annually)

How has PMCB Current Ratio performed in the past?

The mean historical Current Ratio of PharmaCyte Biotech, Inc. over the last ten years is 31.04. The current 45.28 Current Ratio has changed 14.49% with respect to the historical average. Over the past ten years (40 quarters), PMCB's Current Ratio was at its highest in in the October 2021 quarter at 468.40. The Current Ratio was at its lowest in in the January 2020 quarter at 0.21.

PharmaCyte Biotech, Inc. (PMCB) Current Ratio by Quarter and Year

Discovering the peaks and valleys of PharmaCyte Biotech, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

PharmaCyte Biotech, Inc. (PMCB) Average Current Ratio

How has PMCB Current Ratio performed in the past?

The current Current Ratio of PharmaCyte Biotech, Inc. (PMCB) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

PharmaCyte Biotech, Inc. (PMCB) Current Ratio vs. Peers

How is PMCB’s Current Ratio compared to its peers?

PharmaCyte Biotech, Inc.’s Current Ratio is greater than Radiopharm Theranostics Limited (3.01), greater than Quoin Pharmaceuticals, Ltd. (2.87), greater than NovaBay Pharmaceuticals, Inc. (5.29), greater than Alaunos Therapeutics, Inc. (1.63), greater than VivoSim Labs, Inc. (2.38), greater than Impact BioMedical Inc. (0.22), greater than Pasithea Therapeutics Corp. (35.40), greater than Polyrizon Ltd. (29.03), greater than Cyclerion Therapeutics, Inc. (1.80), greater than Brainstorm Cell Therapeutics Inc. (0.02),

Build a custom stock screener for PharmaCyte Biotech, Inc. (PMCB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PharmaCyte Biotech, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PharmaCyte Biotech, Inc. (PMCB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PharmaCyte Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.